February 2021

Total Page:16

File Type:pdf, Size:1020Kb

February 2021 Teacher Enrichment Program February 2021 Perspectives Science Virtual Bite of Science Rebuilding trust brick by brick Spring & Summer Events Calendar Dr. Kizzy Corbett, NIH lead for Moderna Vaccine, in an interview with Dr. Sanjay Gupta, CNN Chief Medical Date Virtual Event Target Area Correspondent February 25 Shenandoah & Technology Western VA COVID-19 warnings were on Twitter March 4 Northern California "Our study adds on to the existing evidence that social media can be a useful tool of epidemiological March 11 Florida surveillance." - Massimo Riccaboni, IMT School March 18 Pennsylvania Social media big data predicts contagion diffusion Information Discovery and Delivery March 25 Coastal & Eastern VA April 8 Texas Engineering Better face masks through origami April 15 Southern California “From basic pleats to complex interlocking folds, April 22 Maryland origami could deliver better fitting, more comfortable, and more stylish face coverings.” - National Geographic May 6 West Virginia May 13 Indiana Mathematics DNA and true random number generation Exploiting the stochastic nature of chemistry through You are invited to sign up for any session of interest, DNA synthesis as a model for encryption and regardless of target area. Find more information about decryption of sensitive information. - Nature each event on the TEP Homepage. Thank you! Timeless STEM The mission of Project Drawdown is to promote global awareness of community- A big thank you to based conservation. Project Drawdown Claude Moore Charitable Foundation, shares information about environmental one of the sponsors of TEP’s impact sectors such as agriculture, Virtual Bite of Science events. transportation, health & education, and Learn more here. more. Visit Project Drawdown here. Lessons to Learn Highlighting Diversity in Educational Resources & Technology Vaccine Development Boeing’s FUTURE U. National Urban League & the NIH Resources for educators - inspire students to Dr. Kizzmekia S. Corbett, Ph.D. create, collaborate, persist, and learn to Dr. “Kizzy” Corbett is a research solve problems that can change the world. fellow at the National Institutes of Experiential learning that fuels innovation! - in collaboration with Discovery Education - Health and the lead scientist for the Coronavirus Vaccines & FUTURE U. Virtual Field Trips Immunopathogenesis Team (NIH Create a curiosity-driven learning Director’s Blog). Her work was praised by Dr. environment in your virtual or in-person Anthony Fauci at a forum hosted by the National classes. Check out interactive aerospace Urban League in December, 2020. technology videos, virtual field trips to The question: “Can you talk about the input of exclusive locations with behind-the-scenes African American scientists in the vaccine content, ‘ecoAction’ environmental process?” Fauci had no hesitation in responding: education, and more! one of the two vaccines with almost 100% efficacy Technovation and safety “was actually developed in my “Technovation is the global tech education institute’s vaccine research center by a team of nonprofit that inspires girls and families to scientists led by Dr. Barney Graham and his close be leaders and problem solvers in their lives colleague, Dr. Kizzmekia Corbett …an African and their community.” American scientist who is right at the forefront of the development of the vaccine.” Technovation Families As a young student, Corbett participated in CREATE A BETTER WORLD TOGETHER “Develop curiosity, creativity and confidence Project SEED, a program for gifted minority through family-friendly, hands-on activities.” students that promoted lab studies at UNC - (formerly Curiosity Machine) Chapel Hill. She later graduated with dual majors in Biological Sciences and Sociology from the Technovation Girls University of Maryland on a “full ride” scholarship. GIRLS FOR A CHANGE She returned to UNC-CH to complete a Ph.D. in “Every year, Technovation invites teams of Microbiology and Immunology. Upon graduation, young people from all over the world to she was appointed to the Vaccine Research learn and apply the skills needed to solve real-world problems through technology.” Center, a division of the National Institute of Allergy and Infectious Diseases at the NIH. Dr. Visit TEP’s Lab Bench for more state and Corbett’s specialized training in viral immunology national resources and programming. made her a key player in the acceleration of the Drawer and Tab: Additional Resources development of the Moderna COVID-19 vaccine. ABC News CBS News American Society for Microbiology .
Recommended publications
  • July 2020 Strategies for Emerging Infectious Diseases
    THE AMERICAN WWW.CAYMANCHEM.COM ASSOCIATION OF IMMUNOLOGISTS AT ISSUE NEW THE DOWNLOAD Virus Life Cycle Infographic Infographic Cycle Life Virus JULY 2020 Resources for Your Research Your for Resources Informative Articles Informative CAYMAN CURRENTS: CAYMAN IN THIS ISSUE OF THE THE OF ISSUE THIS IN DISEASES INFECTIOUS EMERGING AAI Looks Back: How Honolulu’s Chinatown FOR STRATEGIES "Went Up in Smoke" A history of the first plague outbreak in Hawai’i, page 30 ANTIVIRAL 28 No. Permit CAYMAN CURRENTS PA Gettysburg, PAID 20852 20852 20852 20852 MD MD MD MD Rockville, Rockville, Rockville, Rockville, 650, 650, 650, 650, Suite Suite Suite Suite Pike, Pike, Pike, Pike, Rockville Rockville Rockville Rockville 1451 1451 1451 1451 Postage U.S. Non-Proft Org. Non-Proft IMMUNOLOGISTS IMMUNOLOGISTS IMMUNOLOGISTS IMMUNOLOGISTS OF OF OF OF ASSOCIATION ASSOCIATION ASSOCIATION ASSOCIATION AMERICAN AMERICAN AMERICAN AMERICAN THE THE THE THE 2020 advanced Course in Immunology Now Virtual! I July 26–31, 2020 IN THIS ISSUE Director: Wayne M. Yokoyama, M.D. Washington University School of Medicine in St. Louis x4 Executive Offce The American Association Don’t miss the premier course in immunology for research scientists! of Immunologists x8 Public Affairs This intensive course is directed toward advanced trainees and scientists who wish to expand or update 1451 Rockville Pike, Suite 650 their understanding of the feld. Leading experts will present recent advances in the biology of the Rockville, MD 20852 20 Members in the News immune system and address its role in health and disease. This is not an introductory course; Tel: 301-634-7178 attendees will need to have a frm understanding of the principles of immunology.
    [Show full text]
  • COVID-19 Vaccine Weekly Update
    Ramona Whittington From: Roxana Cruz Sent: Tuesday, February 23, 2021 10:02 PM To: [email protected]; [email protected]; Myrta Garcia; Lindsay Lanagan; catherine.threatt; [email protected]; Medical Directors; Dental Directors; [email protected]; [email protected] Cc: ClinicalTeam; Cassandra Caravello; Jana Eubank; Daniel Diaz; Shelby Tracy; Nancy Gilliam; Ramona Whittington Subject: COVID-19 Vaccine Weekly Update: Week 11 (02/22/2021) Attachments: COVIDVaccineAllocation-Week11_final.pdf; americanlungassociation_vaccineeducationtoolkit.pdf; ACP_Addressing Mistrust About COVID-19 Vaccines.pdf; COVIDVaccineAllocation-Week10.pdf Dear Fellow CMOs and Vaccine Coordinators, We hope you are well and that your communities have recovered since last week’s winter storm. As I am sure you know by now, COVID vaccine distribution was put on hold last week 2/15‐ 2/19 (Week 10) due to the inclement weather. Per the weekly DSHS Call today, the following updates were provided: • 100K of 1st dose vaccine not shipped/distributed • 300K of 2nd dose vaccine not shipped/distributed • 1 million vaccine doses will be distributed this week, to include last and this week’s allotments. • 600k 1st doses will go to 563 providers in 230 counties • Mass vaccination clinics this week: Dallas, Tarrant, Harris Counties COVID‐19 Vaccine Weekly Update: Week 11 (02/22/2021) During week 11, there were 61 health center sites that received allocations that total 18,550 doses this week. Vaccine Allocations for Week 11 (02/22/2021) attached w/orange highlighted health center sites. Vaccine Allocations for Week 10 (02/15/2022) although previously sent out, we have attached this list again for your reference.
    [Show full text]
  • Coalition Communication: Healthcare
    Updated 1/15/2021 Coalition Communication: Healthcare COVID-19 UPDATES We need your help in sharing information about the COVID-19 vaccine. KEY STATS Vaccine.coronavirus.ohio.gov is an online resource for Ohioans to learn which providers received a COVID-19 vaccine allotment and how to contact them. Data as of 1/14/2021 Tentative dates to start vaccinating these Phase 1B populations are: • Jan. 19, 2021—Ohioans 80 years of age and older. PUBLIC HEALTH • Jan. 25, 2021—Ohioans 75 years of age and older; those with severe ADVISORY SYSTEM congenital or developmental disorders. • Feb. 1, 2021—Ohioans 70 years of age and older; employees of K-12 schools that wish to remain or return to in-person or hybrid learning. • Feb. 8, 2021—Ohioans 65 years of age and older. When a new age group begins, vaccinations may not be complete for the previous age group. It will take a number of weeks to distribute all of the vaccines given the limited doses available. If you are older than 65, please connect with an Area Agencies on Aging about questions or if you need transportation assistance. For more information, visit aginig.ohio.gov or call 1-866-243-5678. More information can be found at coronavirus.ohio.gov. 21-DAY TRENDS INDUSTRY INFORMATION Case Average 7,316 ■ The Ad Council and the COVID Collaborative have released a series of Death Average 73 videos, available in a YouTube playlist, feature an introduction from Dr. Anthony Fauci and include experts leading healthcare organizations. Hospitalization 293 Average ■ BlackDoctor.org’s Making It Plain: What Black America Needs to Know ICU Admission 29 About COVID-19 and Vaccines aired on January 7 and is now available on- Average demand on YouTube.
    [Show full text]
  • Do Vaccines Reduce Long-COVID Symptoms?
    Do Vaccines Reduce Long-COVID Symptoms? One of the many important questions about long-COVID is whether COVID-19 vaccination can reduce symptoms in those experiencing long-COVID. While some patients report a lessening of symptoms, it is unknown whether this is causally related to the vaccine, or merely reflective of the fact that most patients’ symptoms improve over time. In addition, some patients also report a worsening of symptoms. But since there is currently a poor understanding of the causes and risk factors for long-COVID, all patient experiences following vaccination need to be carefully assessed. For example, one observational and uncontrolled study (not yet peer-reviewed) released in March 2021 compared 44 vaccinated long-COVID patients with 22 “I’ve heard from people who say they no longer matched unvaccinated participants. Those who received the vaccine showed a have ‘brain fog,’ their gastrointestinal problems small overall improvement in long-COVID symptoms, with a decrease in have gone away, or they stopped suffering from worsening symptoms (5.6% vaccinated vs. 14.2% unvaccinated) and increase in the shortness of breath they’ve been living with symptom resolution (23.2% vaccinated vs. 15.4% unvaccinated).1 Additionally, since being diagnosed with COVID-19.” an informal survey of more than 900 patients with long-COVID by Survivor - Akiko Iwasaki, PhD Corps, a patient advocacy group for those with long-COVID, found that only Professor of immunobiology at Yale School of 39% of patients reported improvements following vaccination.
    [Show full text]
  • UMBC Alumnae Racing to Develop Coronavirus Vaccine
    Newsletter SPRING 2020 To our UMBC/Meyerhoff families: We hope you and your families are all doing well during this strange and stressful time of Covid- 19. Although the world has changed quickly with so many things shut down and many of us sheltering at home, we hope this newsletter will represent a ray of sunshine during a dark and difficult time. Please enjoy this positive representation of our student and alumni community. MPA Board UMBC Alumnae Racing to Develop Coronavirus Vaccine Kizzmekia Corbett ’08, M16, biological sciences, says it feels like she’s “living in a constant adrenaline rush.” Maybe that’s because she and her team at the Vaccine Research Center at the National Insti- tute of Allergy and Infectious Diseases have been working around the clock for weeks. They’re racing to develop a vaccine for the coronavirus faster than it can race across the globe. “To be living in this moment where I have the opportunity to work on something that has imminent global importance…it’s just a surre- al moment for me,” Corbett says. Despite it feeling surreal, the advances Corbett and her team are making are very real, and they’re setting records. “We are making better progress than I could have ever hoped for,” she says. After three months of studies in test tubes and in animals, the vaccine her team developed is about to enter a phase I clinical trial, a crucial hur- dle on the way to FDA approval. Read the complete article about Kizzmekia and her team’s efforts to develop a Covid-19 vaccine in the latest UMBC magazine at https:// Kizzmekia Corbett, NIH magazine.umbc.edu/umbc-alumnae-racing-to-develop- coronavirus-vaccine/.
    [Show full text]
  • Covid-19 Vaccination Disparities and Hesitancy
    COVID-19 VACCINATION DISPARITIES AND HESITANCY + Stanley Thompson, MD, MHA, FACEP + David Hogan, DO, MPH, FACEP + Khadeja Haye, MD, MBA, FACOG teamhealth.com COVID-19 VACCINATION DISPARITIES AND HESITANCY Numerous studies have shown that the COVID-19 pandemic has disproportionately affected people of color in the United States. Black, Hispanic or Latinx, and Native American people are approximately four times more likely to be hospitalized and nearly three times more likely to die of COVID-19 than their majority counterparts. There are numerous reasons for these disparities, many of which are the same as other findings of disparity in other disease states (i.e. the social determinants of medicine). We know that vaccination is the key to preventing COVID-19 in all people. Vaccinated People – What We Know America’s vaccination effort is among the best in the world. However, where race is known, people of color are getting vaccinated at lower rates than white Americans. The Kaiser Family Foundation analysis reveals a significant disparity where race is known (about 54%) for those who have received at least one dose of vaccine as of April 13, 2021. It shows the racial/ethnic breakdown as White Americans 65%, Hispanic or Latinx 11%, Black 9%, Asian 5%, Indigenous American or Alaskan 2%, Native Hawaiian <1%, and Multiple race 9%. A YouGov poll further supports and illustrates this point as well. Among White adults polled, 26% have gotten the vaccine, compared to 17% of Black adults and 11% of Hispanic adults. Access to Vaccines A big part of what is occurring is disparate access to vaccination.
    [Show full text]
  • Inland Communities of Color Receiving Vaccinations at Slower Rate, Data Shows – Press Enterprise ___
    2/4/2021 Inland communities of color receiving vaccinations at slower rate, data shows – Press Enterprise ___ NEWS •• News Inland communities of color receiving vaccinations at slower rate, data shows Victorville resident Marvin Abella, 32, receives his second vaccination shot of the Pfizer-BioNTech COVID-19 Vaccine by licensed vocational nurse Mayra Aceves at Arroyo Valley High School in San Bernardino on Thursday, Jan. 28, 2021. 500 second doses were scheduled to be given out Thursday with another 500 scheduled for Friday. (Photo by Will Lester, Inland Valley Daily Bulletin/SCNG) By DEEPA BHARATH || [email protected] || OrangeOrange CountyCounty Register PUBLISHED: February 3, 2021 at 6:42 p.m. || UPDATED:UPDATED: February 3, 2021 at 6:42 p.m. https://www.pe.com/2021/02/03/inland-communities-of-color-receiving-vaccinations-at-slower-rate-data-shows/?utm_medium=social&utm_c… 1/8 2/4/2021 Inland communities of color receiving vaccinations at slower rate, data shows – Press Enterprise Communities of color are behind when it comes to being vaccinated for the coronavirus, a disparity Inland Empire officials say they are working to address. In Riverside County, where 50% of the population is Latino, for example, only 17.9% of those who have been vaccinated are Latino while 44.9% are White, county officials said Wednesday, Feb. 3. Meanwhile, 4.1% of the total number of vaccinations administered have been given to African Americans and 10.7% toto AsianAsian Americans,Americans, whichwhich eacheach representrepresent aboutabout 6.5%6.5% ofof thethe countyʼscountyʼs population. Native American and Pacific Islander residents, who represent 0.8% and 0.3% of the population, respectively, account for 0.6% and 0.7% of thosethose vaccinated.vaccinated.
    [Show full text]
  • Dân Chúa on Line Số 67 - Tháng 1.2021 Nguyệt San Công Giáo Trong Số Này Katholische on Line
    Dân Chúa on line số 67 - tháng 1.2021 Nguyệt San Công Giáo Trong Số Này Katholische on line . Lá Thư Chủ Nhiệm. Monthly Catholic on line . Lịch Phụng vụ tháng Một 2021. Email: [email protected] . Năm Mục vụ Giới Trẻ 2021. Herausgeber: Franz Xaver e.V. Ghen và ghét. Dân Chúa Katholische on line . Khi Nào Trẻ Em DÂN CHÚA ÂU CHÂU Có Thể Chích Ngừa Covid-19? Chủ nhiệm: Lm Stêphanô Bùi Thượng Lưu . Những Ai Đã Góp Phần Sáng Chế Phụ tá chủ nhiệm: Lm Paul Đào Văn Thạnh Thuốc Ngừa Covid-19?. Thư ký : Sr. Anne Marie Nguyễn Thị Hường . Khát vọng Hòa Bình. Chủ biên thần học : Lm Vincent Lê Phú Hải omi . Đánh giá đời sống thiêng liêng Chủ biên văn hóa: Sh Bonaventure Trần Công Lao qua 4 điểm cốt yếu. hình bìa : Trần Anh Dũng omi. Một năm đặc biệt để làm chứng DÂN CHÚA ÚC CHÂU cho tình yêu gia đình. 715 Sydney Rd. Brunswick, Victoria 3056 . Loài Người Đã Được Tạo Dựng Tel.: (03) 9386-7455 / Fax: (03) 9386-3326 Hay Do Tiến Hóa?. Chủ nhiệm: Lm. Nguyễn Hữu Quảng SDB . Nguồn gốc vũ trụ theo Thánh Kinh Chủ bút: Rev. James Võ Thanh Xuân và khoa học. Phụ tá Chủ bút: Trần Vũ Trụ . Thiên Chúa Sáng Tạo Vũ Trụ Tổng Thư Ký: Sr. Nguyễn Thùy Linh, FMA Và Con Người. Ban kỹ thuật: Hiệp Hải . Trái đất có thể khóc không?. NHÀ KHẢO CỔ NGƯỜI ANH TIN RẰNG Mục đích & Tôn CHỈ Dân Chúa ÔNG ĐÃ TÌM THẤY NGÔI NHÀ Mục đích: Góp phần vào việc phục vụ tập thể Công THỜI THƠ ẤU CỦA CHÚA GIÊSU Giáo Việt Nam và đồng bào để cùng thăng tiến toàn .
    [Show full text]
  • What Contributes to COVID-19 Vaccine Hesitancy in Black Communities, and How Can It Be Addressed?
    Research Report C O R P O R A T I O N LAURA M. BOGART, LU DONG, PRIYA GANDHI, SAMANTHA RYAN, TERRY L. SMITH, DAVID J. KLEIN, LUCKIE ALEXANDER FULLER, BISOLA O. OJIKUTU What Contributes to COVID-19 Vaccine Hesitancy in Black Communities, and How Can It Be Addressed? ecent polls show that Black Americans are less willing than Americans of other races or ethnicities to be vaccinated for COVID-19, even after the November 2020 announcements by pharmaceutical companies Pfizer and BioNTech and Moderna about their vaccines’ R 1 high efficacy. For example, responses to a November 2020 poll of an online survey panel found that 42 percent of Black Americans, versus 63 percent of Hispanic or Latinx Americans and 61 percent of White Americans, said that they would definitely or probably get vaccinated.2 A December 2020 nationally representative telephone poll found that 35 percent of Black adults said KEY FINDINGS that they would definitely not or Q A survey of a nationally representative sample of 207 Black Ameri- probably not get vaccinated3—and cans conducted in late 2020 found high levels of vaccine hesitancy about half of those who did not and mistrust of COVID-19 vaccines in the overall sample, as well as want to get vaccinated cited mistrust among health care workers in particular. of vaccines as well as worry about Q Those who expressed vaccine hesitancy also showed high levels getting COVID-19 from the vaccine of overall mistrust, concerns about potential harm and side effects, as main reasons. Evidence thus and lack of confidence in vaccine effectiveness and safety.
    [Show full text]
  • Newsletter Spring 2021
    A Year Like No Other - the 2020 UGSP Newsletter Written and Assembled by UGSP Newsletter Committee Charlesice Grable-Hawkins (Chair), Nyree Riley, Makheni Jean-Pierre “Each time new experiments are observed to agree with the predictions the theory survives, and our confidence in it is increased; but if ever a new observation is found to disagree, we have to abandon or modify the theory.” - Dr. Stephen Hawking From the global push to develop a vaccine, institutional restructuring, and changing schedules to the massive transition into a virtual environment, the year of 2020 was nothing like anyone could have planned for. This near universal experience has led many to reassess the working model of their everyday lives, to reflect and experiment with how they approach their wellness and their connections with others, and to think critically about moving forward. The Undergraduate Scholarship Program, under the direction of Dr. Darryl Murray, continues to support students who are from disadvantaged backgrounds and who are passionate about advancing biomedical, behavioral, and social science fields for the improvement of human health. This newsletter will highlight some of the ways in which current UGSP scholars have adapted to the challenges of 2020, provide insight into the perspective of both a mentee and mentor, as well as how UGSP alumni Dr. Kizzmekia Corbett has contributed to the development of the Moderna SARS-CoV-2 vaccine. Table of Contents Dr. Kizzmekia Corbett – a Powerful Voice in Science During COVID-19 ....................................................... 2 Current Scholars ............................................................................................................................................ 3 UGSP Alum and Mentor Reflections ............................................................................................................. 4 Dr. Darryl Murray’s go-to wellness activity over this past year has been walking his family’s new rescue dog Pepper! Dr.
    [Show full text]
  • March 11, 2021
    Sector Email 3.11.2021 Subject header: Updates on COVID-19 from Public Health - Seattle & King County (PHSKC) Schools Dear school partners, March is Women’s History Month and this year we are grateful to some of the women who are making history by changing the course of the COVID-19 pandemic. Have you learned about Kizzmekia Corbett, an African American Immunologist who co-led the development of the Moderna COVID-19 vaccine. This month, we celebrate Dr. Corbett and thousands of her colleagues in healthcare, research and public health as women who are making history. Reminder: please review the King County Schools COVID-19 Response Toolkit, related resources, and training videos. ---------- This week’s Public Health—Seattle & King County (PHSKC) Schools and Child Care Task Force sector email includes the following topics: 1. Key indicators of COVID-19 activity 2. Vaccine Updates a. Educators, school staff and child care workers now eligible for COVID-19 vaccine b. How school and child care staff can access vaccines c. Getting Vaccinated Resources d. Signs and Symptoms Following Vaccination 3. COVID Community Vaccination Event Planning Workbooks 4. Special Enrollment for Washington Health Care 5. Updated Mask Posters 6. Events a. Public Health’s upcoming trainings and community discussions on COVID-19 b. COVID-19 Vaccination Webinar and Q&A c. COVID-19 Vaccine Distribution Webinar and Q&A d. Oromo Session – COVID-19 and Vaccinations e. Somali Session – COVID-19 and Vaccinations 7. Updated Guidance from the CDC – When You’ve Been Fully Vaccinated 8. School and District Town Hall Meetings 9.
    [Show full text]
  • Kizzmekia S. Corbett
    KIZZMEKIA S. CORBETT, PHD Senior Research Fellow National Institutes of Health | National Institute of Allergy and Infectious Diseases | Vaccine Research Center 40 Convent Drive, Building 40 - Room 2608, Bethesda MD 20892 [email protected] | phone: 301.761.7610 | fax: 301.480.2771 EDUCATION Doctor of Philosophy in Microbiology and Immunology 2014 University of North Carolina at Chapel Hill (UNC) Director’s Scholar Bachelor of Science in Biological Sciences | Secondary Major in Sociology 2008 University of Maryland – Baltimore County (UMBC) Robert and Jane Meyerhoff Scholar RESEARCH EXPERIENCE Research Fellow 10/14 - present National Institutes of Health | Vaccine Research Center | PI: Barney S. Graham, MD PhD Research Interest: mechanisms of viral immunity to inform influenza and coronavirus vaccine development Graduate Research Assistant 08/09 – 10/14 University of North Carolina at Chapel Hill | Microbiology and Immunology | PI: Aravinda de Silva, MPH PhD Research Interest: human antibody responses to dengue virus infection Visiting Scholar 04/14 – 05/14 Genetech Research Institute | PI: Aruna Dharshan de Silva, PhD Research Interest: immunological relevance of dengue virion maturation Postbaccalaureate Research Fellow 05/08 – 08/09 National Institutes of Health | Vaccine Research Center | PI: Barney S. Graham, MD PhD Research Interest: novel vaccine platform design for respiratory syncytial virus antigens NIH Undergraduate Scholarship Program Summer Intern 06/07 – 08/07 National Institutes of Health | Vaccine Research Center
    [Show full text]